Nefopam
- Generic Name
- Nefopam
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19NO
- CAS Number
- 13669-70-0
- Unique Ingredient Identifier
- 4UP8060B7J
- Background
Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.
- Indication
用于术后镇痛、癌痛、急性外伤痛。亦可用于急性胃炎、胆道蛔虫症、输尿管结石等内脏平滑肌收缩绞痛；局部麻醉、针麻等麻醉辅助用药。
- Associated Conditions
- Pain
Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation
- Conditions
- Kidney Transplantation
- Interventions
- Drug: Normal saline
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- Severance Hospital
- Target Recruit Count
- 98
- Registration Number
- NCT01622881
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Non Opioid Treatment for Experimental Dyspnea
- First Posted Date
- 2012-04-13
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 15
- Registration Number
- NCT01577407
- Locations
- 🇫🇷
Pitié salpetriere Hospital, Paris, France
Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery
- Conditions
- PainOrthognathic Surgery
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- The Catholic University of Korea
- Target Recruit Count
- 40
- Registration Number
- NCT01461031
- Locations
- 🇰🇷
Seoul St.Mary's Hospital, Seoul, Seocho-gu, Korea, Republic of
Effects of Nefopam on Hyperalgesia After Cardiac Surgery
- Conditions
- HyperalgesiaPain, PostoperativePain, Chronic Disease
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- University Hospital, Bordeaux
- Target Recruit Count
- 90
- Registration Number
- NCT00413257
- Locations
- 🇫🇷
Département d'Anesthésie-Réanimation II - Hôpital cardiologique - Groupe Hospitalier Sud, CHU de Bordeaux - 4, Av de Magellan, Pessac, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.